Pharmaceutical Executive Digest:
Having trouble viewing this e-mail? Click here.

 
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.

Pharmaceutical Executive Europe  E-News
 
 
 
 
 
 

You can now follow us on Twitter at Twitter.com/pharmexecdigi
 
Survey
We asked 40 pharma executives, What is your company's main driver for outsourcing biologics?

Cost control 39%
Technical 26%
capabilities 8%
Risk management 9%
Speed to market 18%

Talk to us:
editor@pharmexeceurope.com

Advertise with us: jgray@advanstar.com


1 November, 2011
In this Issue
EC Probes J&J and Novartis
The European Commission has launched an antitrust investigation to examine whether contracts between Johnson & Johnson (J&J) and Novartis were designed to delay the market entry of generic versions of Fentanyl in the Netherlands. More...
Going Global: The Next Stage of Patient Engagement?
Given the level of influence that regulators in Germany and the UK have over global pricing and reimbursement, and ultimately, access, it is becoming crucial for patients to participate in the process as much as possible, writes Ben Comer.
More...
The Patient's Footprint: 30 Years of Patient Advocacy
The rise of advocacy groups has helped patients find their voice, but the power to change health profiles remains an elusive goal, writes Jennifer Ringler.
More...
Global Transparency Reporting Congress — London 2012
Register now for CBI's Global Transparency Reporting Congress, to be held in London 28–29 February, 2012, and save £152! More...
Also in this issue…
Sweden: Setting the Pace for Global Pharma
New Foreign Investment Plans for India
Merck, Sharpe and Dohme Announce Singapore Investments

Product Profile
NNIT

GxP Cloud - business enablement for Life Sciences only
NNIT has built an enhanced cloud allowing Life Science companies to enjoy all the benefits from cloud computing and still fulfill the GxP requirement.
Read more


Event Profile

Key Account Management Europe 2011
The KAM paradigm continues to dictate current and future pharma strategy – how can you perfect the KAM approach? This is the only account management specific conference in Europe: Listen and learn from big pharma, global industries and key stakeholders.
Read more

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone
numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other
opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.com or by mail

at Advanstar Communications Inc., Bridgegate Pavilion, 4A Chester Business Park, Wrexham Road, Chester, CH4 9QH, UK